Martín-Villa J M, Martínez-Laso J, Moreno-Pelayo M A, Castro-Panete M J, Martínez-Quiles N, Alvarez M, de Juan M D, Gómez-Reino J J, Arnaiz-Villena A
Department of Immunology, Hospital Nta, Sra de Aránzazu, San Sebastián, Spain.
Ann Rheum Dis. 1998 Apr;57(4):214-9. doi: 10.1136/ard.57.4.214.
To study the influence MHC class II and TAP2 alleles exert on systemic lupus erythematosus (SLE) susceptibility and on the clinical and serological manifestations of the disease, in a cohort of Spanish patients.
HLA-DR serological typing and HLA-DQA, DQB, and TAP2 DNA sequence specific oligotyping, were carried out in 85 unrelated Spanish SLE patients and 186 healthy controls. Autoantibodies detection was carried out by indirect immunofluorescence and counter immunoelectrophoresis.
Total SLE group: the frequency of HLA-DR3 and HLA-DQA10501 is significantly increased in this group (pc < 0.005, delta = 0.34 and pc < 0.005, delta = 0.45, respectively) although the highest delta value (delta = 0.87) is obtained when the TAP201 alleles are considered. No DQB allele shows significant deviation from the control group. Renal damage: it mainly occurs in HLA-DR3 patients (pc < 0.0005 and delta = 0.72). HLA-DQA10501 (p < 0.05, delta = 0.57 and DQB10201 (pc NS, delta = 0.56) are weaker susceptibility factors. Ro+ (but not LA) group: this autoantibody response is associated with TAP201 alleles in homozygosity (p < 0.05, delta = 0.81). R0/La+ group: it has a different genetic background as HLA-DQA10501 (delta = 1) and HLA-DQB1*0201 (delta = 1) are the main susceptibility factors.
A differential association between HLA-DR, DQA1, and DQB1 alleles and SLE or its clinical and serological manifestations are found. Furthermore, the associations are different to the ones reported in other ethnic groups. Finally, TAP201 group of alleles are associated with the highest susceptibility to SLE (higher than HLA-DR3) and may influence Ro (but not La) autoantibodies production, whereas HLA-DQA10501 and DQB1*0201 mediates concomitant Ro and La productions.
在一组西班牙患者中,研究MHCⅡ类分子和TAP2等位基因对系统性红斑狼疮(SLE)易感性以及该疾病临床和血清学表现的影响。
对85名无亲缘关系的西班牙SLE患者和186名健康对照者进行HLA - DR血清学分型以及HLA - DQA、DQB和TAP2 DNA序列特异性寡核苷酸分型。通过间接免疫荧光和对流免疫电泳检测自身抗体。
SLE总组:该组中HLA - DR3和HLA - DQA10501的频率显著增加(分别为pc < 0.005,δ = 0.34和pc < 0.005,δ = 0.45),不过当考虑TAP201等位基因时,获得最高的δ值(δ = 0.87)。没有DQB等位基因显示与对照组有显著偏差。肾脏损害:主要发生在HLA - DR3患者中(pc < 0.0005,δ = 0.72)。HLA - DQA10501(p < 0.05,δ = 0.57)和DQB10201(pc无显著差异,δ = 0.56)是较弱的易感因素。Ro阳性(但La阴性)组:这种自身抗体反应与纯合子TAP201等位基因相关(p < 0.05,δ = 0.81)。Ro/La阳性组:其遗传背景不同,因为HLA - DQA10501(δ = 1)和HLA - DQB1*0201(δ = 1)是主要的易感因素。
发现HLA - DR、DQA1和DQB1等位基因与SLE或其临床和血清学表现之间存在差异关联。此外,这些关联与其他种族群体中报道的不同。最后,TAP201等位基因组与SLE的最高易感性相关(高于HLA - DR3),可能影响Ro(但不影响La)自身抗体的产生,而HLA - DQA10501和DQB1*0201介导Ro和La抗体的同时产生。